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OBJECTIVE—This study assesses -cell replication in human
donor organs and examines possible inﬂuences of the pretermi-
nal clinical conditions.
RESEARCH DESIGN AND METHODS—-Cell replication
was quantiﬁed in a consecutive series of n  363 human organ
donors using double immunohistochemistry for Ki67 and insulin.
Uni- and multivariate analysis was used to correlate replication
levels to clinical donor characteristics and histopathologic
ﬁndings.
RESULTS—-Cell replication was virtually absent in most do-
nors, with 0.1% Ki67-positive -cells in 72% of donors. A
subpopulation of donors, however, showed markedly elevated
levels of replication of up to 7.0% Ki67-positive -cells. -Cell
replication was accompanied by the increased replication of
glucagon-, somatostatin-, and CA19.9-positive cells. Prolonged
life support, kidney dysfunction, relatively young donor age,
inﬂammatory inﬁltration, and prolonged brain death before or-
gan retrieval were all found to be signiﬁcantly associated with an
increased level (90th percentile) of -cell replication, with the
ﬁrst three risk factors being independent predictors. Increased
-cell replication was most often noted in relatively young
donors (25 years) who received prolonged (3 days) life
support (68%); in contrast, it was rare in donors with a short
duration of life support regardless of age (1%). Prolonged life
support was accompanied by increased levels of CD68
 and
LCA/CD45
 inﬁltration in the pancreatic parenchyma.
CONCLUSION—These results indicate that preterminal clinical
conditions in (young) organ donors can lead to increased inﬂam-
matory inﬁltration of the pancreas and to increased -cell
replication. Diabetes 59:1702–1708, 2010
H
uman diabetes is a heterogeneous group of
disorders with increased glycemia levels and a
decreased functional -cell mass in common.
Type 1A diabetes is characterized by a T-cell–
mediated autoimmune destruction of 50–70% of -cell
mass at clinical onset, whereas type 2 diabetes is charac-
terized by a smaller decrease in -cell mass in association
with insulin resistance and loss of -cell function (1,2).
Clinical interventions aimed at restoring a functionally
adequate endogenous -cell mass are therefore of consid-
erable interest, but they are hampered by a relative lack of
knowledge about the in vivo conditions that stimulate
-cell replication and neoformation in the adult pancreas
(3). Quantiﬁcation of -cell replication in the developing
human pancreas shows that replication is high in the early
fetal pancreas, but decreases rapidly after birth and is only
rarely observed in the adult pancreas (4–7). Interestingly,
several cases have been described in which patients with
a variety of diseases, including lobar pneumonia, hemo-
chromatosis, or acute liver disease, were reported to
display prominent mitotic activity in adult islet tissue
(8–10). Such chance observations indicate that although
replication in the adult pancreas is normally low, adult
human islet cells apparently do retain a capacity for
replication that can be activated under selected clinical
conditions. To characterize such conditions we investigated
-cell replication in a large consecutive series of human
organ donors and correlated our ﬁndings to the preterminal
clinical characteristics of the patients involved.
RESEARCH DESIGN AND METHODS
Collection of pancreatic tissue. Pancreas biopsy specimens were obtained
from the Beta Cell Bank in Brussels, which operates for a clinical trial on islet
cell transplantation in Belgium (11). The biopsy specimens were taken as part
of a quality control procedure that was approved by the medical ethics
committee of our university. A single biopsy specimen of 0.5 cm
3 was taken
from the body region of the cold-preserved (University of Wisconsin preser-
vation solution ﬂushed) donor pancreas immediately before the remaining
tissue was digested for islet isolation. Biopsy specimens were ﬁxed in 4% (v/v)
phosphate-buffered formaldehyde, pH 7.4, and embedded in parafﬁn for routine
histopathologic examination. Tissue blocks from 363 of 500 consecutive donors
fulﬁlled all inclusion criteria (minimal biopsy surface area 0.25 cm
2; minimal
clinical data including age, sex, BMI, time in hospital, cause of death; and
availability of a serum sample) and were analyzed by immunohistochemistry.
Immunohistochemistry. Consecutive 4-m parafﬁn sections were immuno-
histochemically double stained for the replication marker Ki67 (mouse
anti-Ki67; Dako, Glostrup, Denmark) and insulin (guinea pig anti-insulin; a gift
of Dr. Van Schravendijk, Brussels Free University, Brussels, Belgium), gluca-
gon (rabbit anti-glucagon; Dr. Van Schravendijk), somatostatin (rabbit anti-
SRIF; a gift of Dr. De Mey, Brussels Free University) or synaptophysin (rabbit
anti-synaptophysin; Dako). Rabbit anti-Ki67 (Acris Antibodies, Hiddenhausen,
Germany) was used in conjunction with mouse anti-carbohydrate antigen-19.9
(Novocastra Laboratories, Newcastle upon Tyne, U.K.) and with mouse
anti-LCA/CD45 (Clones 2B11 plus PD7/26; Dako). Double stainings were also
performed using rabbit anti-phosphohistone H3 (Upstate Biotechnology, Lake
Placid, NY), mouse anti-LCA (Dako), mouse anti-CD68 (clone KP1; Dako) or
mouse anti-CD3 (Novocastra Laboratories), and guinea pig anti-insulin. Bind-
ing of primary antibodies was detected with biotinylated anti-mouse or
anti-rabbit Ig (Amersham, Little Chalfont, U.K.) or biotinylated anti-guinea pig
Ig (Vector Laboratories, Burlingame, CA) in combination with streptavidin
horseradish peroxidase or alkaline phosphatase complex (both from Dako).
For immunoﬂuorescence microscopy the following second antibodies were
used: FITC anti-rabbit Ig, AMCA anti-guinea pig Ig, FITC anti-guinea pig Ig,
Cy3 anti-mouse Ig, Cy3 anti-rabbit Ig (all from Jackson ImmunoResearch
Laboratories, West Grove, PA), Alexa Fluor 488 anti-guinea pig and anti-rabbit
Ig, and Alexa Fluor 647 anti-rabbit and anti-mouse Ig (all from Invitrogen,
Carlsbad, CA).
Quantiﬁcation of replication and relative -cell area. Islet cell replica-
tion was assessed in slides double stained for the replication marker Ki67 and
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sin. Ductal cell replication was assessed in slides double stained for the
replication marker Ki67 and for the ductal marker carbohydrate antigen-19.9.
All quantitative analyses were performed by transmitted light microscopy on
coded slides at a ﬁnal magniﬁcation of 400 by two independent observers.
Minimally 1,000 cells per case were evaluated, except for glucagon and
somatostatin for which 400 and 100 cells per case were evaluated, respec-
tively. Relative -cell area was determined according to Rahier et al. (12) on
immunostained sections using a 180-point counting grid at a ﬁnal magniﬁca-
tion of 140. The number of points overlaying insulin immunoreactive cells
(Ni) and parenchyma (Np) was counted in 20 random microscope ﬁelds per
case. Grid points overlaying the lumen of ducts, arteries, connective tissue, or
fatty tissue were not included in the analysis. Relative -cell area was
calculated as (Ni/Np)  100 and expressed as a percentage. All morphometric
analyses were carried out in a blinded fashion on coded slides by two
independent observers.
Quantiﬁcation of leukocytic inﬁltration. Leukocytic inﬁltration was as-
sessed in slides double stained for insulin and leukocyte common antigen
(LCA/CD45), CD68, or CD3. The number of inﬁltrating CD68
 and LCA/CD45

cells was quantiﬁed at a ﬁnal magniﬁcation of 400 and is expressed as
mean  SE of cell numbers per 10 high power microscope ﬁelds (correspond-
ing to a total area of 2.83 mm
2).
Clinical and histopathologic parameters. Selected clinical parameters
were obtained from the donor information forms and from the Eurotransplant
Foundation (Leiden, the Netherlands). Because of the anonymity of the organ
donors, clinical data could not always be veriﬁed and were sometimes
incomplete or not available for all donors. We tested whether the following 13
clinical (13) and histopathologic risk factors were associated with increased
-cell replication: young donor age (25 years), high BMI (30 kg/m
2),
prolonged time in the intensive care unit (3 days), prolonged duration of
mechanical respiration (3 days), increased inﬁltration of CD68
 monocytic
cells in the pancreatic parenchyma (deﬁned as 90th percentile in organ
donors with a minimal [	1 day] stay in the intensive care unit, corresponding
to a level of 175 CD68
 cells per 10 high power microscope ﬁelds), increased
inﬁltration of LCA/CD45
 leukocytes in the pancreatic parenchyma (deﬁned
as 90th percentile in organ donors with a minimal [	1 day] stay in the
intensive care unit, corresponding to a level of 115 LCA/CD45 cells per 10
high power microscope ﬁelds), hypotensive periods (systemic blood pressure
	100 mmHg), prolonged duration of brain death (12 h to start of cold
perfusion as deﬁned by the third quartile), kidney damage (serum creatinine
150 mol/l), liver damage (bilirubin 2 mg/dl combined with aspartate
aminotransferase 25 units/l), pancreas damage (amylase 200 units/l, de-
ﬁned as twice the reference value), hyperglycemia (glucose 200 mg/dl), and
the reported use of steroid hormones during the stay in the intensive care unit.
Serum fructosamine and C-peptide levels were tested retrospectively on
samples stored at 
80°C.
Statistical analysis. Differences between groups were assessed by a Mann-
Whitney U test for continuous variables and by a 
2 test with Yates’ correction,
or Fisher’s exact test, whenever appropriate, for categorical variables. Clinical
and biologic characteristics of organ donors were studied after stratiﬁcation
for -cell replication level (donors with -cell replication level below percen-
tile 90 [P90] [	0.6%] vs. donors with levels above P90 [0.6%]). Logistic
regression analysis was performed with -cell replication level as dependent
variable, with inclusion of all variables with P  0.10 in univariate analysis
(i.e., time in the intensive care unit, kidney damage, age, monocytic inﬁltra-
tion, leukocytic inﬁltration, duration of brain death, reported use of steroid
hormones, and pancreas damage). Duration of mechanical ventilation was not
included as a variable because of the number of missing data and the good
correlation with time in the intensive care unit (correlation coefﬁcient 0.63
[95% CI0.56–0.71]; P 	 0.001). Statistical tests were performed two-tailed
using SPSS for Windows PASW 17 (SPSS, Chicago, IL) for personal computers
and considered signiﬁcant at P 	 0.05 (multivariate analysis) or, in the case of
k-independent univariate comparisons, at P 	 0.05/k (Bonferroni correction).
Only risk factors with an odds ratio (OR) 95% CI that excluded 1.0 were
considered predictive.
RESULTS
Increased -cell replication is found in a subset of
organ donors. In a consecutive series of n  363 donor
pancreata (donor age 2–75 years), immunohistochemical
double staining for the replication marker Ki67 and insulin
indicated for most organs (72%) a low level of replication
(0.1%) in the 1,000 -cells that were evaluated for each
organ. The remaining donors (28%) presented levels of
-cell replication between 0.2 and 7.0% (Table 1). Donors
with a high level of replication (deﬁned as 90th percen-
tile; n  36 patients) were between 6 and 66 years of age,
with different causes of death (Table 2). The replicating
-cells were found scattered throughout the islets (Fig.
1A–D); they were only infrequently found to be associated
with ducts. Donors who showed increased levels of Ki67-
positive -cells also presented with mitotic ﬁgures and
cells that costained for insulin and the G2 to M transition
marker phosphohistone H3 (Fig. 1E and F). When the n 
36 donors with a high level of -cell replication were
compared with the n  327 donors with a lower level of
-cell replication, they were found to be of signiﬁcantly
younger median age (29 vs. 48 years; P 	 0.0001; Table 2),
whereas BMI in the two groups was comparable. A high
male-to-female ratio (24 male vs. 12 female donors) in the
group of donors with high -cell replication was most
probably caused by the high number of male donors in the
youngest age group (37 male vs. 14 female donors in the
age-group 25 years vs. 189 male and 172 female donors in
the total study population; sex data on two patients were
missing).
Relative -cell area in organ donors with a high level
of -cell replication. When the relative -cell area was
determined in the group with high replication (90th
percentile; 36 patients) a mean relative -cell area of
1.78  0.18% was found. This mean relative area was
higher, but not statistically different, from that found in the
n  36 matched (age, sex, and BMI) controls from the
group with a low level of -cell replication (1.28  0.05%;
P  0.085). To assess whether severe -cell degranulation
could have inﬂuenced quantiﬁcation of -cell area, we
performed double labeling for the -cell transcription
factor Nkx6.1 and insulin in a subset of donors from both
groups. It was observed that most (90%) Nkx6.1-positive
cells also showed cytoplasmic insulin immunoreactivity,
indicating that the majority of -cells were insulin-positive
and that the fraction of severely degranulated “hidden”
-cells was relatively low (Fig. 1G and H).
Increased -cell replication is accompanied by an
increase in both endocrine and exocrine cell replica-
tion. Immunohistochemical double labeling for Ki67 and
the islet cell markers glucagon and somatostatin showed
that a 20-fold higher mean level of -cell replication in the
90th percentile group was accompanied by a 52-fold
higher level of -cell replication and a ﬁvefold higher level
of 
-cell replication (Figs. 1I–L and 2). Virtually all repli-
cating islet cells showed positivity for the panendocrine
marker synaptophysin (Fig. 1M and N). Replication was
not only observed in islet cells but also throughout the
pancreatic parenchyma outside the islets where it was
observed in acinar cells and ductal cells (Fig. 1O and P).
Ductal replication was quantiﬁed on Ki67/CA19.9 coimmu-
nostained slides and a 3.7-fold higher level of ductal cell
TABLE 1
Frequency distribution of patients with different levels of -cell
replication
-Cell replication
level n %
0.1% 262 72.2
0.2–0.5% 65 17.9
0.6–1.0% 23 6.3
1.0% 13 3.6
Total 363 100
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cation (Fig. 2).
Increased -cell replication is associated with pro-
longed duration of life support and young donor age.
Multi- and univariate analysis was performed to test 13
clinical parameters (risk factors) for their association with
-cell replication. Thirty-six donors with a high level of
-cell replication (90th percentile) were compared with
the n  327 patients with low replication (	90th percen-
tile). Seven risk factors showed a signiﬁcant association in
univariate analysis: prolonged duration of mechanical res-
piration (OR31.1), prolonged duration of stay in an the
intensive care unit (24.5), kidney dysfunction (7.1), young
donor age (6.7), increased CD68
 monocytic inﬁltration
(6.2), increased LCA/CD45
 leukocytic inﬁltration (3.7),
and a prolonged duration of brain death (3.0). Three of
these parameters were found to be independent predictors
of -cell replication in multivariate analysis: young donor
age, prolonged duration of stay in an intensive care unit,
and kidney dysfunction (Table 3). High -cell replication
levels were observed in 15 of 22 (68%) donors who
combined prolonged life support with young donor age
(25 years), which is signiﬁcantly more frequent than in
donors of the same age with shorter duration of life
support (1 of 28 or 4%; P 	 0.001, 
2 test) (Table 4).
Comparison with the older age-group shows that in older
patients, the prevalence of high replication levels is less
and occurs after a more prolonged stay in an intensive
care unit. Regardless of donor age, the average frequency
of high replication was 1% in donors with 	3 days stay in
an intensive care unit. Average duration of mechanical
ventilation was 6  3 days in the 90th percentile group
vs. 2  2 days for the 	90th percentile group (P 	 0.001).
Six clinical parameters, including hyperglycemia and use
of steroid hormones, showed no signiﬁcant association
with increased -cell replication. As blood glucose values
TABLE 2
Characteristics of donors with a high level of -cell replication (90th percentile)
Donor
-Cell replication
level (%) Age (years)/Sex
BMI
(kg/m
2) Cause of death
1 7.0 18/M 22 Cerebrovascular accident
2 5.8 18/M 24 Craniocerebral trauma
3 5.5 19/M 26 Polytrauma, brain edema
4 3.2 6/M 13 Inhalation trauma
5 3.2 55/F 21 Subarachnoid bleeding
6 2.6 13/F 14 Cerebellar infarction
7 2.5 30/M 23 Craniocerebral trauma
8 2.5 42/M 27 Craniocerebral trauma
9 1.8 36/M 26 Craniocerebral trauma
10 1.8 19/M 23 Medulloblastoma
11 1.6 39/F 24 Aneurysm
12 1.2 30/M 22 Craniocerebral trauma
13 1.2 26/F 23 Hypoxia
14 1.0 20/M 31 Cerebral trauma
15 1.0 23/M 22 Craniocerebral trauma
16 1.0 25/M 22 Hanging (suicide)
17 1.0 25/M 30 Craniocerebral trauma
18 1.0 53/M 27 Intracranial bleeding
19 0.9 18/M 23 Craniocerebral trauma
20 0.9 38/M 28 Strangling (suicide)
21 0.8 27/M 26 Polytrauma
22 0.7 66/M 28 Subarachnoid bleeding
23 0.7 24/M 24 Craniocerebral trauma
24 0.7 46/F 31 Intracranial bleeding
25 0.7 41/M 29 Hypoxia brain damage
26 0.7 19/F 26 Craniocerebral trauma
27 0.7 30/F 23 Brain edema
28 0.7 19/M 24 Craniocerebral trauma
29 0.7 36/F 24 Subarachnoid bleeding
30 0.7 44/F 28 Intracranial bleeding
31 0.6 59/F 25 Cerebrovascular (ischemia)
32 0.6 54/F 31 Subarachnoid bleeding
33 0.6 42/M 25 Subarachnoid bleeding
34 0.6 22/F 20 Craniocerebral trauma
35 0.6 63/M 32 Subarachnoid bleeding
36 0.6 20/M 20 Brain edema (hanging)
All donors with high
replication (n  36) 1.0 (0.7–1.8) 29 (20–42) 24M/12F 24 (22–28)
Matched controls with low
replication (n  36) 0 (0–0.1) 28 (21–42) 24M/12F 24 (22–26)
All donors with low
replication (n  327) 0 (0–0.1) 48 (37–54) 165M/160F 24 (22–26)
Data are medians (interquartile range) unless otherwise speciﬁed. F, female; M, male.
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a surrogate marker for prolonged hyperglycemia and
compared levels of circulating C-peptide. We found no
signiﬁcant difference in the level of serum fructosamine
between the 36 donors with high replication (152  31
mol/l) and their 36 matched controls (175  24 mol/l),
nor did we ﬁnd signiﬁcant differences in the level of
circulating C-peptide (1.75  3.22 vs. 1.35  2.43 g/l).
Prolonged duration of life support is associated with
increased inﬂammatory inﬁltration. Immunohisto-
chemical staining for CD68 showed a diffuse inﬁltration of
positive cells throughout the pancreatic parenchyma. The
inﬁltration was variable between patients but was most
pronounced in the group with high replication and in
patients on prolonged life support (Fig. 3A and B). Small
numbers of CD68
 cells were observed in the islet inter-
stitium, but no apparent colocalization with islet cell
replication was found. Immunohistochemical staining for
LCA/CD45 and CD3 showed focal areas of inﬁltration
around the vasculature, in the interstitial connective tis-
sue, and in the parenchyma, but was rare in islets (Fig.
3C–F). Quantiﬁcation showed that prolonged life support
was accompanied by a signiﬁcantly increased inﬁltration
of CD68
 and LCA/CD45
 cells in both young and older
donors, with the increase in CD68 positivity preceding the
increase in LCA/CD45 positivity (Table 5). Donors with
high -cell replication (90th percentile; n  36 patients)
showed a signiﬁcant (P 	 0.001) 1.7-fold increase in CD68
positivity (274  26 vs. 161  18), and a signiﬁcant (P 	
0.001) 2.0-fold increase in LCA/CD45 positivity (85  12 vs.
43  6) when compared with n  36 matched patients
with low replication.
DISCUSSION
In the present study we investigated -cell replication
levels in the normal human pancreas. We identiﬁed a
subgroup of organ donors who presented with increased
levels of -cell replication and correlated our ﬁndings to
the periterminal clinical conditions of the patients in-
volved. We report that a prolonged period on life support
(3 days), kidney dysfunction, a relatively young donor
age (25 years), inﬂammatory inﬁltration, and a prolonged
period of brain death before organ retrieval were all found
to be signiﬁcantly associated with an increased level
(90th percentile) of -cell replication. The effect was
most pronounced in young donors who received pro-
longed life support; in contrast, it was rare in donors with
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FIG. 1. Imunohistochemical double staining for replication markers and pancreatic cell type–speciﬁc markers in parafﬁn sections of human donor
pancreas. Donors with a relatively high level of -cell replication (>90th percentile) (high) show increased replication in endocrine and ductal
cell types compared with donors with a low level of -cell replication (<90th percentile) (low). Representative images are shown. Staining for
Ki67 (brown) and insulin (red) shows replicating cells in and around islets of Langerhans (A and B; 70); part of the replicating islet cells
correspond to insulin-positive -cells (C and D; blue arrows; 200). Staining for the G2 to M transition marker phosphohistone H3 (brown) and
insulin (red) shows an immunopositive mitotic -cell (E and F; blue arrow; 200). Staining for the transcription factor Nkx6.1 (brown) and
insulin (red) shows colocalization of the two markers (G and H; 200). Staining for Ki67 (brown) and glucagon (red) shows replicating -cells
(I and J; blue arrows; 200). Double staining for Ki67 (brown) and somatostatin (red) shows replicating -cells (K and L; blue arrows; 200).
Double staining for Ki67 (brown) and the panendocrine marker synaptophysin (red) shows replicating endocrine islet cells (M and N; 200).
Double labeling for Ki67 (brown) and the ductal marker CA19.9 (red) shows replicating ductal cells (O and P; blue arrow; 200). (A high-quality
digital representation of this ﬁgure is available in the online issue.)
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increase in replicative rate was not limited to -cells but
was also observed in -cells, 
-cells, and ductal cells. We
found that prolonged life support was associated with
increased pancreatic inﬁltration of both CD68
 monocytic
cells and LCA/CD45
 leukocytes. The increase in CD68
positivity appeared to precede the increase in LCA/CD45
positivity by several days. These results indicate that
preterminal clinical conditions in organ donors can lead to
both increased inﬂammatory inﬁltration of the pancreatic
parenchyma and to an activation of -cell replication that
is most pronounced in patients in the younger age
category.
Replication of adult human -cells is a rare ﬁnding in
histopathologic studies of human pancreas. In a study of
327 autopsy cases, only 14 patients were found to express
one or more mitotic ﬁgures in the islets of Langerhans (9).
In a similar study of 174 autopsy cases, only 18 patients
showed one or more islet cell mitoses (10). Both studies
were limited by the lack of speciﬁc immunohistochemical
techniques to identify islet cell types and by the lack of
sensitive techniques for the detection of islet cell replica-
tion. More recent studies, using immunohistochemistry for
the nuclear marker Ki67 that is expressed during late G1,S ,
M and G2 phases of the cell cycle, found that -cell
replication decreased progressively from 3.2% at 17–32
weeks of gestation to 1.1% perinatally (5). After birth, the
degree of -cell replication was found to drop further, with
initial levels being sufﬁcient to account for the expansion
of -cell mass from birth to adulthood, but with -cell
replication levels decreasing hyperbolically with age to
reach levels that are generally 	0.1% in young adults (6,7).
The low level of -cell replication in the adult pancreas is
supported by our present studies in which 72% of donors
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FIG. 2. Replication levels in insulin-positive -cells (Ins), glucagon-
positive -cells (Gluc), somatostatin-positive -cells (Som), and
carbohydrate antigen 19.9–positive ductal cells (CA19.9) as deter-
mined by double immunohistochemistry for Ki-67. Donors with a high
level of -cell replication (>90th percentile; n  36; f) are compared
with matched controls (<90th percentile; n  36; ). Results are
expressed as means  SE; signiﬁcance of difference with the control
condition was calculated with a nonparametric Mann-Whitney U test:
*P < 0.001; †P  0.002; ‡P  0.016.
TABLE 3
Clinical and histopathologic parameters associated with a high level of -cell replication
Risk factors
-Cell replication level Univariate Multivariate
	90th
percentile
90th
percentile OR (95% CI) P value OR (95% CI) P value
n 327 36
Mechanical respiration 3 days 54/183 13/14 31.1 (4.0–243.3) 	0.001 — —
Intensive care unit 3 days 132/322 34/36 24.5 (5.8–103.6) 	0.001 16.2 (3.2–88.2) 0.001
Kidney dysfunction 11/324 7/35 7.1 (2.6–20.0) 	0.001 10.9 (2.3–52.6) 0.003
Age 25 years 35/326 16/36 6.7 (3.2–14.0) 	0.001 17.4 (5.3–57.1) 	0.001
Increased CD68 inﬁltration 97/327 26/36 6.2 (2.9–13.3) 	0.001 2.0 (0.6–6.0) 0.240
Increased LCA inﬁltration 42/327 13/36 3.9 (1.8–8.1) 	0.001 3.2 (1.0–9.9) 0.046
Brain death 12 h 91/321 19/35 3.0 (1.5–6.1) 0.002 2.8 (1.0–7.8) 0.043
Use of steroids 28/327 7/36 2.6 (1.0–6.4) 0.042 3.8 (0.9–15.8) 0.062
BMI 30 kg/m
2 19/327 4/36 2.0 (0.6–6.3) 0.224 — —
Hyperglycemia 71/300 7/36 0.8 (0.3–1.9) 0.572 — —
Hypotensive periods 93/203 14/31 1.0 (0.5–2.1) 0.946 — —
Liver damage 1/30 1/36 0.8 (0.5–13.8) 0.896 — —
Pancreas damage 64/237 4/36 0.3 (0.1–1.0) 0.049 0.5 (0.1–1.8) 0.287
Uni- and multivariate analysis were performed to test the association between 13 clinical and histopathologic parameters (risk factors) and
high levels of -cell replication (90th percentile) including prolonged duration of mechanical respiration (3 days), prolonged time in the
intensive care unit (3 days), kidney dysfunction (serum creatinine 150 mol/l), young donor age (25 years), increased CD68
 cell
inﬁltration (90th percentile), increased LCA/CD45
 cell inﬁltration (90th percentile), prolonged duration of brain death (12 h to start
of cold perfusion), the use of steroid hormones (yes/no), high BMI (30 kg/m
2), hyperglycemia (glucose 200 mg/dl), hypotensive periods
(systemic blood pressure 	100 mmHg), liver damage (bilirubin 2 mg/dl combined with aspartate aminotransferase 25 units/l), and
pancreas damage (amylase 200 units/l). Logistic regression analysis was performed with -cell replication level as a dependent variable,
with inclusion of all variables with P  0.10 in univariate analysis. Duration of mechanical ventilation was not included as a variable because
of the number of missing data and the good correlation with time in the intensive care unit.
TABLE 4
Donors with a high level of -cell replication (90th percentile)
stratiﬁed according to donor age and duration of stay in the
intensive care unit
Age
Time in intensive care unit
Total 	3 days 3–5 days 6 days
25 years 1/28 (3.6) 8/13 (61)*† 7/9 (78)*† 16/50 (32)†
25 years 1/164 (0.6) 2/76 (2.6) 17/68 (25)* 20/308 (6.5)
Total 2/192 (1.0) 10/89 (11)* 24/77 (31)* 36/358 (10)
Data are fraction (%). *P 	 0.001 vs. 	3 days in the intensive care
unit. †P 	 0.001 vs. equivalent condition 25 years.
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remaining donors presented with replication levels that
were signiﬁcantly higher (0.2–7.0%), reaching levels nor-
mally found only in early fetal pancreas (4–6).
In the studied donor organs, high levels of -cell repli-
cation were found to be accompanied by an increased
replication of -cells, 
-cells, and ductal cells. The increase
in replication thus appears to be a generalized phenome-
non with virtually all pancreatic cell types being induced
into a replicative state. In patients with a high replicative
activity, we also noted the presence of mitotic ﬁgures
inside the islets of Langerhans and positivity for the G2 to
M transition marker phosphohistone H3, albeit at a much
lower frequency than that of Ki67 positivity. These obser-
vations indicate that Ki67-positive cells are driven toward a
proliferative pathway, rather than toward a polyploid state
that is relatively frequent in normal human pancreas (14).
When the 10% of patients with the highest replication
level (P90) were correlated with the available clinical data,
a signiﬁcant association was found with a prolonged
duration of life support, kidney dysfunction, relatively
young donor age, inﬂammatory inﬁltration, and a pro-
longed period of brain death. A total of 68% of patients
with both a prolonged life support and young donor age
were found to present with high levels of -cell replica-
tion, in contrast with 1% of patients with a shorter duration
of life support, irrespective of age. These observations
suggest that -cell replication was induced only after
admission to the hospital and took several days to de-
velop: donors with high levels of replication had a duration
of mechanical respiration that on average exceeded 6
days, whereas donors with low replication were on aver-
age mechanically respirated for 2 days. The mechanism
behind this induction is unknown, but several hypotheses
can be proposed.
A ﬁrst possibility is that it is caused by prolonged
treatment with drugs that are known to induce -cell
replication: patients in the intensive care unit often receive
treatment with high doses of steroids, which were shown
to induce a marked elevation of plasma insulin levels and
20- to 30-fold higher levels of islet cell replication in
primates (15). However, we did not ﬁnd any evidence for
this possibility: treatment with steroids was not signiﬁ-
cantly associated with high -cell replication, although the
duration of drug treatment was not always known and the
use of steroids may not always have been registered in
the donor ﬁle. We therefore also tested for differences in
circulating C-peptide levels, as steroid treatment was
reported to result in increased circulating insulin levels
(15), but no signiﬁcant differences were observed.
A second possibility is that a prolonged period of
hyperglycemia may contribute to the induction of -cell
replication in these patients. Although no signiﬁcant dif-
ferences in plasma glycemia could be found between the
two groups, it cannot be excluded that such differences
did exist before the time point of blood sampling just
before death. We therefore measured fructosamine levels
as a surrogate marker for prolonged hyperglycemia but did
not ﬁnd any evidence for a signiﬁcant difference between
the two groups.
A third possibility is that -cell replication is activated
by a prolonged period of hypoxia leading to cellular
damage as might be the case in the subpopulation of
patients with extended life support. The presence of
higher numbers of CD68
 macrophages and LCA/CD45

leukocytes seen dispersed throughout the pancreatic pa-
renchyma in such patients may be indicative of cellular
damage, and the macrophages may be involved in clearing
cellular debris. It is so far not known which signals are
responsible for the proliferative stimulus. Cytokines may
be released by pancreatic cells such as ductal cells (16), as
well as by the inﬁltrating monocytes and leukocytes.
Release of proinﬂammatory cytokines and/or leukocytic
inﬁltration has been described in both human donor
kidney and liver (17,18) and in rodent islets after brain
death (19). Several recent studies suggested that -cell
replication and neogenesis are stimulated by inﬂammatory
lesions induced by autoimmunity (20–23) or injury (24).
Follow-up studies will be necessary to dissect the mecha-
nism of the replicative response that is described in the
present report. Gene expression analysis of human pan-
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FIG. 3. Immunohistochemical staining for monocytic and leukocytic
inﬁltration markers in parafﬁn sections of human donor pancreas.
Donors with a relatively high level of -cell replication (>90th percen-
tile) (high) have increased inﬂammatory inﬁltration compared with
donors with low level of -cell replication (<90th percentile) (low).
Representative images are shown. Double staining for CD68 (brown)
and the panendocrine marker synaptophysin (red) (A and B; 70),
LCA/CD45 (brown) and synaptophysin (red) (C and D; 70), and CD3
(brown) and synaptophysin (red) (E and F; 70). (A high-quality
digital representation of this ﬁgure is available in the online issue.)
TABLE 5
Mean number of inﬁltrating CD68
 monocytes and LCA/CD45

leucocytes stratiﬁed according to donor age and duration of stay
in the intensive care unit
Age Marker
Time in intensive care unit
	3 days 3–5 days 6 days
25 years CD68 116  14 152  20* 343  50†
LCA/CD45 34  53 4  16 116  24†
25 years CD68 115  5 168  11† 281  17†
LCA/CD45 57  46 0  59 3  11*
All ages CD68 115  4 166  10† 283  16†
LCA/CD45 54  35 8  69 6  10†
Data are means  SE of cell numbers per 10 high power microscope
ﬁelds. *P 	 0.05 vs. 	3 days in the intensive care unit. †P 	 0.001.
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the present study may indicate the nature of the factors
involved. Exposure of isolated human islets to proinﬂam-
matory cytokines in vitro may help establish their stimu-
latory effect on -cell replication.
Our observation of increased inﬂammatory inﬁltration
throughout the pancreatic parenchyma in organ donors
with extended life support is also relevant in the context of
islet transplantation. It cannot be excluded that islets
isolated from such donors may either contain higher
numbers of passenger leukocytes or that islet cells are
activated by cytokine exposure leading to changed allo-
graft reactivity. It also warrants caution in the interpreta-
tion of histopathologic changes in postmortem pancreas in
the context of presumed autoimmune lesions and stresses
the importance of obtaining control groups that are ade-
quately matched in terms of clinical history.
The presence of replicating -cells in adult organ donors
indicates that although such cells are rare under normal
circumstances, they have retained their potential for
growth and can be induced to enter the mitotic cycle upon
activation by preterminal clinical conditions. Alternatively,
replicating cells may be derived from progenitor cells (24)
or from existing adult cells, such as peripheral blood
monocytes (25), by a process of transdifferentiation.
In summary, we have quantiﬁed -cell replication in a
large consecutive series of human organ donors and found
evidence that a subgroup of donors present with high
levels of replication in pancreatic endocrine cells, includ-
ing islet -cells. Multivariate analysis of clinical data
showed that high levels of replication were signiﬁcantly
and independently associated with extended life support,
kidney damage, and young donor age. These patients were
also characterized by signiﬁcantly increased levels of
inﬂammatory inﬁltration in the pancreatic parenchyma.
The results indicate that preterminal clinical conditions in
organ donors can activate -cell replication. Elucidation of
the cellular and molecular pathways involved in this
process may help researchers devise new strategies for
stimulating -cell growth in vivo.
ACKNOWLEDGMENTS
These studies were supported by grants from the Fonds
voor Wetenschappelijk Onderzoek Vlaanderen (G028908),
the Vrije Universiteit Brussel, and the Juvenile Diabetes
Research Foundation (26-2008-896).
No potential conﬂicts of interest relevant to this article
were reported.
We thank Sabrina D’Haese, Sylvie Duys, and Greet Van
Wichelen for expert technical assistance.
REFERENCES
1. Daneman D. Type 1 diabetes. Lancet 2006;367:847–858
2. Pipeleers D, Chintinne M, Denys B, Martens G, Keymeulen B, Gorus F.
Restoring a functional beta cell mass in diabetes. Diabetes Obes Metab
2008;10(Suppl. 4):54–62
3. Meier JJ. Beta cell mass in diabetes: a realistic therapeutic target?
Diabetologia 2008;51:703–713
4. Bouwens L, Lu WG, De Krijger R. Proliferation and differentiation in the
human fetal endocrine pancreas. Diabetologia 1997;40:398–404
5. Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B. Beta-cell
proliferation and apoptosis in the developing normal human pancreas and
in hyperinsulinism of infancy. Diabetes 2000;49:1325–1333
6. Meier JJ, Butler AE, Saisho Y, Monchamp T, Galasso R, Bhushan A, Rizza
RA, Butler PC. Beta-cell replication is the primary mechanism subserving
the postnatal expansion of beta-cell mass in humans. Diabetes 2008;57:
1584–1594
7. Bouwens L, Pipeleers DG. Extra-insular beta cells associated with ductules
are frequent in adult human pancreas. Diabetologia 1998;41:629–633
8. Warren S, Root HF. The pathology of diabetes, with special reference to
pancreatic regeneration. Am J Pathol 1925;1:415–429
9. LeCompte PM, Merriam JC. Mitotic ﬁgures and enlarged nuclei in the
islands of Langerhans in man. Diabetes 1962;11:35–39
10. Potvliege P, Gepts W, Carpent G. U ¨ ber das vorkommen von mitosen in den
inselzellen des menschlichen pankreas. Beitr Pathol Anat 1963;128:335–
346
11. Keymeulen B, Gillard P, Mathieu C, Movahedi B, Maleux G, Delvaux G,
Ysebaert D, Roep B, Vandemeulebroucke E, Marichal M, In’t Veld P,
Bogdani M, Hendrieckx C, Gorus F, Ling Z, van Rood J, Pipeleers D.
Correlation between beta cell mass and glycemic control in type 1 diabetic
recipients of islet cell graft. Proc Natl Acad Sci USA 2006;103:17444–17449
12. Rahier J, Wallon J, Henquin JC. Cell populations in the endocrine pancreas
of human neonates and infants. Diabetologia 1981;20:540–546
13. Lefering R, Goris RJ, van Nieuwenhoven EJ, Neugebauer E. Revision of the
multiple organ failure score. Langenbecks Arch Surg 2002;387:14–20
14. Ehrie MG, Swartz FJ. Diploid, tetraploid and octaploid beta cells in the
islets of Langerhans of the normal human pancreas. Diabetes 1974;23:583–
588
15. Like AA, Chick WL. Pancreatic beta cell replication induced by glucocor-
ticoids in subhuman primates. Am J Pathol 1974;75:329–348
16. Movahedi B, Van de Casteele M, Caluwe ´ N, Stange ´ G, Breckpot K,
Thielemans K, Vreugdenhil G, Mathieu C, Pipeleers D. Human pancreatic
duct cells can produce tumour necrosis factor- that damages neighbour-
ing beta cells and activates dendritic cells. Diabetologia 2004;47:998–1008
17. Nijboer WN, Schuurs TA, van der Hoeven JA, Leuvenink HG, van der Heide
JJ, van Goor H, Ploeg RJ. Effects of brain death on stress and inﬂammatory
response in the human donor kidney. Transplant Proc 2005;37:367–369
18. Jassem W, Koo DD, Cerundolo L, Rela M, Heaton ND, Fuggle SV.
Leucocyte inﬁltration and inﬂammatory antigen expression in cadaveric
and living-donor livers before transplant. Transplantation 2003;75:2001–
2007
19. Toyama H, Takada M, Suzuki Y, Kuroda Y. Activation of macrophage-
associated molecules after brain death in islets. Cell Transplant 2003;12:
27–32
20. Sreenan S, Pick AJ, Levisetti M, Baldwin AC, Pugh W, Polonsky KS.
Increased beta-cell proliferation and reduced mass before diabetes onset
in the nonobese diabetic mouse. Diabetes 1999;48:989–996
21. Sherry NA, Kushner JA, Glandt M, Kitamura T, Brillantes AM, Herold KC.
Effects of autoimmunity and immune therapy on beta cell turnover in type
1 diabetes. Diabetes 2006;55:3238–3245
22. In’t Veld P, Lievens D, De Grijse J, Ling Z, Van der Auwera B, Pipeleers-
Marichal M, Gorus F, Pipeleers D. Screening for insulitis in adult autoan-
tibody-positive organ donors. Diabetes 2007;56:2400–2404
23. Meier JJ, Lin JC, Butler AE, Galasso R, Martinez DS, Butler PC. Direct
evidence of attempted beta cell regeneration in an 89-year-old patient with
recent-onset type 1 diabetes. Diabetologia 2006;49:1838–1844
24. Xu X, D’Hoker J, Stange ´ G, Bonne ´ S, De Leu N, Xiao X, Van de Casteele M,
Mellitzer G, Ling Z, Pipeleers D, Bouwens L, Scharfmann R, Gradwohl G,
Heimberg H. Beta cells can be generated from endogenous progenitors in
injured adult mouse pancreas. Cell 2008;132:197–207
25. Ruhnke M, Ungefroren H, Nussler A, Martin F, Brulport M, Schormann W,
Hengstler JG, Klapper W, Ulrichs K, Hutchinson JA, Soria B, Parwaresch
RM, Heeckt P, Kremer B, Fa ¨ndrich F. Differentiation of in vitro-modiﬁed
human peripheral blood monocytes into hepatocyte-like and pancreatic
islet-like cells. Gastroenterology 2005;128:1774–1786
-CELL REPLICATION IN HUMAN DONOR PANCREAS
1708 DIABETES, VOL. 59, JULY 2010 diabetes.diabetesjournals.org